Hogan Lovells has added a partner to its health practice in Washington, the firm announced earlier this week.
Christine Bloomquist, formerly senior director of federal government affairs with AstraZeneca Pharmaceuticals, was the chief healthcare lobbyist for the company. She advised the company both before and after the passage of the Affordable Care Act.
Bloomquist will focus her practice on advising pharmaceutical and medical device companies on fraud and abuse compliance; pricing; and regulatory and policy matters.
“I come to Hogan with a much deeper understanding of how the business side works and I saw that first hand,” Bloomquist said in an interview. “I think I bring to the table a combination of regulatory and legislative experience.”